Abstract
The rationale for the design of structural analogues of a normal metabolite is that such compounds may interfere in the utilization or function of the metabolite. A compound which is effective in this respect may be called an antimetabolite. To be successful in chemotherapy of bacterial, viral, or tumor growth, an antimetabolite should adversely affect some vital metabolic reactions in the parasite or parasitic tissue without seriously endangering the host tissue. If a metabolic process of the offending growth is different from that of the host, it is likely that the metabolism or activity of a compound, structurally related to a metabolite involved in that process, will also be different in these cells. Such differences are useful for devising effective drugs with selective actions. Sulfanilamide, a structural analogue of para-aminobenzoic acid, interferes with the utilization of this metabolite in the synthesis of folic acid, an essential factor for growth. Bacteria synthesize their own folic acid and are incapable of utilizing exogenously available folic acid. However, the situation is exactly opposite in the animal host. That is, animal tissues cannot synthesize folic acid and are absolutely dependent upon exogenous sources. These differences in metabolism make possible the use of sulfanilamide as a selective inhibitor of growth. Other antibacterial or antiparasitic drugs, such as penicillin (Burchall, Ferone and Hitchings, 1965) and inhibitors of dihydrofolate reductase (Hitchings and Burchall, 1965; Hitchings, 1964; Burchall and Hitchings, 1965) have analogous desirable selective toxicity effects. Unfortunately, there are few qualitative differences in the metabolism of normal and neoplastic tissues. This fact has made the selective toxicity approach less applicable to cancer chemotherapy. However, it has become increasingly clear that there are quantitative differences which can be utilized as a rational approach to cancer chemotherapy. These considerations are based on the rate of metabolism and the state of cellular structures and are directly related to the rapid growth and multiplication of neoplastic cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Roy-Burman, P. (1970). Introduction. In: Roy-Burman, P. (eds) Analogues of Nucleic Acid Components. Recent Results in Cancer Research, vol 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85576-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-85576-4_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85578-8
Online ISBN: 978-3-642-85576-4
eBook Packages: Springer Book Archive